1. |
Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: First Human case description. Circulation, 2002, 106(24): 3006-3008.
|
2. |
Writing Committee Members, Otto CM, Nishimura RA, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: Executive summary: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol, 2021, 77(4): 450-500.
|
3. |
Yousef A, Simard T, Webb J, et al. Transcatheter aortic valve implantation in patients with bicuspid aortic valve: A patient level multi-center analysis. Int J Cardiol, 2015, 189: 282-288.
|
4. |
Dvir D, Webb JG, Bleiziffer S, et al. Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. JAMA, 2014, 312(2): 162-170.
|
5. |
Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Rev Esp Cardiol (Engl Ed), 2022, 75(6): 524.
|
6. |
Nalluri N, Atti V, Munir AB, et al. Valve in valve transcatheter aortic valve implantation (ViV-TAVI) versus redo-Surgical aortic valve replacement (redo-SAVR): A systematic review and meta-analysis. J Interv Cardiol, 2018, 31(5): 661-671.
|
7. |
Malik AH, Yandrapalli S, Zaid S, et al. Valve-in-valve transcatheter implantation versus redo surgical aortic valve replacement. Am J Cardiol, 2020, 125(9): 1378-1384.
|
8. |
Wenaweser P, Buellesfeld L, Gerckens U, et al. Percutaneous aortic valve replacement for severe aortic regurgitation in degenerated bioprosthesis: The first valve in valve procedure using the Corevalve Revalving system. Catheter Cardiovasc Interv, 2007, 70(5): 760-764.
|
9. |
Bruno F, Elia E, D'Ascenzo F, et al. Valve-in-valve transcatheter aortic valve replacement or re-surgical aortic valve replacement in degenerated bioprostheses: A systematic review and meta-analysis of short and midterm results. Catheter Cardiovasc Interv, 2022, 100(1): 122-130.
|
10. |
Jakobsen L, Terkelsen CJ, Søndergaard L, et al. Short- and long-term mortality and stroke risk after transcatheter aortic valve implantation. Am J Cardiol, 2018, 121(1): 78-85.
|
11. |
Bajrangee A, Coughlan JJ, Teehan S, et al. Early and mid-term outcomes after transcatheter aortic valve implantation (TAVI) in Ireland. Int J Cardiol Heart Vasc, 2017, 16: 1-3.
|
12. |
D'Errigo P, Moretti C, D'Ascenzo F, et al. Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis in patients with chronic kidney disease stages 3b to 5. Ann Thorac Surg, 2016, 102(2): 540-547.
|
13. |
Silaschi M, Wendler O, Seiffert M, et al. Transcatheter valve-in-valve implantation versus redo surgical aortic valve replacement in patients with failed aortic bioprostheses. Interact Cardiovasc Thorac Surg, 2017, 24(1): 63-70.
|
14. |
Saji M, Higuchi R, Izumi Y, et al. Transcatheter aortic valve replacement in patients with extremely severe aortic stenosis. Int J Cardiol, 2021, 329: 162-166.
|
15. |
Webb JG, Dvir D. Transcatheter aortic valve replacement for bioprosthetic aortic valve failure: The valve-in-valve procedure. Circulation, 2013, 127(25): 2542-2550.
|
16. |
Ribeiro HB, Rodés-Cabau J, Blanke P, et al. Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: Insights from the VIVID registry. Eur Heart J, 2018, 39(8): 687-695.
|
17. |
Bernardi FLM, Dvir D, Rodes-Cabau J, et al. Valve-in-valve challenges: How to avoid coronary obstruction. Front Cardiovasc Med, 2019, 6: 120.
|
18. |
Dvir D, Webb JG, Bleiziffer S, et al. Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. JAMA, 2014, 312(2): 162-170.
|
19. |
Costa G, Criscione E, Todaro D, et al. Long-term transcatheter aortic valve durability. Interv Cardiol, 2019, 14(2): 62-69.
|
20. |
Marin F, Scarsini R, Kotronias RA, et al. Aortic valve disease and associated complex CAD: The interventional approach. J Clin Med, 2021, 10(5): 946.
|
21. |
Dziewierz A. The time is always right to do what is right: TAVI and timing of PCI. Int J Cardiol, 2023, 371: 128-129.
|
22. |
Çelik M, Durko AP, Head SJ, et al. Coronary revascularization after surgical aortic valve replacement. JTCVS Open, 2020, 3: 91-101.
|
23. |
Lim Y, Tan KA, Kuntjoro I, et al. Coronary artery disease in patients undergoing transvalvular aortic valve implantation. Interv Cardiol, 2022, 17: e13.
|
24. |
Goel SS, Ige M, Tuzcu EM, et al. Severe aortic stenosis and coronary artery disease: Implications for management in the transcatheter aortic valve replacement era: A comprehensive review. J Am Coll Cardiol, 2013, 62(1): 1-10.
|
25. |
Venturi G, Pighi M, Pesarini G, et al. Contrast-induced acute kidney injury in patients undergoing TAVI compared with coronary interventions. J Am Heart Assoc, 2020, 9(16): e017194.
|
26. |
Ochiai T, Yoon SH, Flint N, et al. Timing and outcomes of percutaneous coronary intervention in patients who underwent transcatheter aortic valve implantation. Am J Cardiol, 2020, 125(9): 1361-1368.
|